ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Changes to PEP recommendations

  • Font size: Larger Smaller
  • Hits: 921
  • Print

Quick update on a presentation by John McAllister

 

  • if source VL is undetectable, then PEP is no longer recommended
    • however, do need to discuss the reliability of the history of undetectable VL
  • Truvada should be used for PEP
    • avoid tenofovir and lamivudine (although cheaper)
  • 3-drug PEP
    • if 3 drugs are needed, then stick with dolutegravir (ALT increases by 22%), raltegravir or rilpiravine

 

  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Monday, 24 February 2020

#INHSU20 scholarship applications are currently open! Applications close Sunday 15 March 2020. Click here to apply:… https://t.co/DpRUSDqfhv

ASHM ASHM

Pfizer has discontinued the supply of FASIGYN (tinidazole) 500 mg tablet blister pack and SIMPLOTAN (tinidazole) 50… https://t.co/j44RNPsRSh

ASHM ASHM

#INHSU20 scholarship applications are currently open! Applications close Sunday 15 March 2020. Click here to apply:… https://t.co/3oRV5tuq9z

ASHM ASHM